We have a new plan of attack. A Phase One trial by a Massachusetts drug company called Syntha. STA-9090 is an inhibitor of Heat Shock Protein (hsp)90. If you want to learn more about this drug, click here
I will tell you more next week, after I do all the preliminary tests at Dana-Farber.